Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Aug 24 2020

Full Issue

As Stalemate On Relief Efforts Persists, GOP And Democrats Exchange Barbs

White House Chief of Staff Mark Meadows over the weekend criticized House Speaker Nancy Pelosi for the lack of progress and she returned the favor. Meanwhile, millions of Americans are facing dire economic realities. In other news, The New York Times reports that administration officials have suggested to congressional leaders that a vaccine may be approved even before Phase 3 trials are complete. The administration denies that.

Reuters: Republicans, Democrats Trade Blame For Stalled U.S. Coronavirus Aid Legislation 

Top Democrats and Republicans blamed each other for stalled talks on coronavirus aid legislation on Sunday, a day after the House of Representatives approved $25 billion in new funds for the U.S. Postal Service, a bill that Republicans declared dead. The Democratic-led House passed the bill on Saturday in a special session called by House Speaker Nancy Pelosi to prevent dwindling Postal Service funding and planned service cuts from interfering with delivery of mail-in ballots for the Nov. 3 election. (Lawder and Hesson, 8/23)

The Washington Post: Debt, Eviction And Hunger: Millions Fall Back Into Crisis As Stimulus And Safety Nets Vanish

One of the most successful elements of the government’s response to the coronavirus recession — protecting people on the margins from falling into poverty — is faltering as the safety net shrinks and federal benefits expire. Major recessions are especially fraught for low-income earners, whose finances can veer from tenuous to dire with one missed paycheck. But as the economy cratered this spring, economists and poverty experts were mildly surprised to discover that the torrent of government support that followed — particularly the $600 a week in expanded unemployment benefits and one-time $1,200 stimulus checks — likely lowered the overall poverty rate. (Denham and Telford, 8/23)

The New York Times: Trump Aides, Meeting With Lawmakers, Reportedly Said A Vaccine Would Be Approved Before The Election

Trump administration officials met with congressional leaders last month and told them they would probably give emergency approval to a coronavirus vaccine before the end of Phase 3 clinical trials in the United States, perhaps as early as late September, according to two people briefed on the discussion. The move would be highly unusual and would most likely prompt concerns about whether the administration is cutting corners on approvals for political purposes. (8/23)

The Hill: Economist Moore Predicts 'Exuberance' In Financial Markets If Coronavirus Cases Decline, Schools Reopen 

Economist Stephen Moore said a potential decline in coronavirus cases and the reopening of schools could lead to an “exuberance” in financial markets. “If that happens, you're going to see a lot of exuberance, not just in the financial markets, but in the real economy as we can start to get schools re-open,” Moore told radio host John Catsimatidis on his show broadcast on WABC 770 AM Sunday. (Moreno, 8/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, June 9
  • Monday, June 8
  • Friday, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF